Galera Therapeutics raised $37,000,000 on , from Correlation Ventures, Galera Angels, ....

Get alertedif Galera Therapeutics gets funded!
Investors:, , , ,
United States
St Louis
Key people:Robert Beardsley (CEO, Director, Executive Officer, Executive_Officer)
Phillip Buckler (Executive_Officer)
Dr. Campbell Murray (Board of Directors)
Eric Gulve (Director)
Jeffery Keene (Executive_Officer)
Catherine Matthes (Executive_Officer)
Dennis Riley (Executive_Officer)
Mel Sorensen (Executive Officer)
Joel Sussman (Executive Officer)
Randy Weiss (Executive_Officer)
Data sources: - Galera Therapeutics, a #biotech company developing new treatments for #cancer patients, closes $37m #venturecapital - Galera received $37M in Series B Funding - Galera Therapeutics Raises $37 Million in Series B Financing - FierceBiotech - Galera Therapeutics Raises $37 Million in Series B Financing - MarketWatch - Galera Therapeutics raised $37M in Series B funds in a venture round to fund work on selective dismutase mimetics: - RT @talent4boards: Galera Therapeutics adds Thomas Dyrberg to #BoardOfDirectors along with completion $37m Series B #financing… - Healthcare & Life Sciences Private Equity Deal Tracker: Galera Therapeutics Secures $37 Million ...: Galera, h...
A 37M round of financing was completed by Galera Therapeutics, a St. Louis, United States-based provider of Medical devices and equipment solutions. The transaction was completed in October 14th, 2015.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!